Brainstorm Health: Pause to Continue, Multiplayer VR Surgeries, Drug Price Freezes
Good morning, Dailies. Happy Friday. I spent the first part of the week at FORTUNE Brainstorm Tech in Aspen, a gathering of leaders and thinkers who seemed—to me, at least—to deliver nonstop insight and surprise for three solid days. (Here’s a landing page to our YouTube Channel, which can take you directly to some of these conversations.)
But one of the highlights for me happened to be off-camera: It was a roundtable discussion Tuesday afternoon on the “New Science of Fitness” with former professional cyclist George Hincapie, EXOS founder and president Mark Verstegen, HVMN CEO Geoff Woo, and Siobhan McFeeney, global leader for business transformation at tech firm Pivotal.
We talked about how better data tracking and interpretation can help us recover from injury much faster and improve mobility; how smarter data and mobile tech can enable us to be proactive in our health and help us avoid body breakdowns; how more personalized nutrition data and sensors can fine-tune our metabolisms and promote wellbeing…and well, noticing a theme here?
Yup, it was all about data and technology.
That is, until Siobhan McFeeney spoke up. I asked McFeeney, a serious amateur climber who has twice climbed Everest, how technology had changed her sport, and she said:
“I climbed my very first mountain many, many years ago. We had leather boots, which weren’t ideal. And then the first time I climbed Everest, we had plastic boots, which were amazing. They were phenomenal compared to what we had before. And then when I climbed the mountain in 2015, honestly it was unbelievable. Gear was warmer, lighter. The O2 sat [blood oxygen saturation] monitor was incredibly precise. We had space stuff, honestly. And I would see people at 27,000 feet, with their perfect technology telling them their blood oxygen level was in the teens—the machine is telling them to STOP and turn around!—and they’re saying, ‘Yeah, I think I can handle it.’ I’m like, ‘You’ve got about 15 minutes…um, to live.’ But human beings are human beings and I think that’s the wild card. The technology is amazing, the data is fantastic. And you still have to be able to draw your own line on yourself to make reasonable decisions under pressure.”
The next day, on the conference main-stage, the writer and New York Times columnist Tom Friedman was talking about how he’d arrived at the title for his most recent big-thinkin’ bestseller, Thank You for Being Late: An Optimist’s Guide to Thriving in the Age of Accelerations.
Friedman was used to setting up breakfast meetings with sources and just as used to having them show up late, he said. But on one particular morning, the delay allowed him some quiet reflection that let him eavesdrop on a neighboring table’s conversation—and, ultimately, to connect two disparate trains of thought in his mind that had been nagging at him for some time. When his guest arrived, spilling out apologies, Friedman thanked him for being late. It was just enough downtime to help him think clearly.
The downtime wasn’t planned; it was thrust upon him. But Friedman had seized upon the opportunity.
Later, he shared a lesson he’d learned from his teacher and moral coach Dov Seidman, the CEO of LRN. “When you press the pause button on a computer, it stops,” Seidman told him. “When you press the pause button on a human being, he or she goes.”
We talk a lot in this column about the digital technology that’s going to change healthcare—and our lives. But in the end, none of that fancy high-tech stuff is going to save us from ourselves. Or make us better than ourselves.
In sum, there is no Human 2.0. There’s just the beta version, and I’d argue that’s a good thing.
With that, we’re giving our Brainstorm Health newsletter a bit of a summer pause. I’m on vacation now, enjoying a Rocky Mountain break in beautiful Colorado for the next week. And Sy is off to Spain and Portugal. So we’re going to let this field lay fallow for next week. We’ll be back on Monday, July 30. Hope you all enjoy the week.
|Clifton Leaf, Editor in Chief, FORTUNE|
Multiplayer VR…for surgeries? We’ve previously reported on how virtual reality technology is helping some health systems train their surgical residents. But what is that process could be turned into a multiplayer virtual exercise? That’s the goal of Osso VR’s latest feature, which allows multiple surgeons to interact with each other via a single VR platform. “We have seen multiplayer VR become the norm in the gaming world and take off in social applications,” said Osso VR CEO Dr. Justin Barad in a statement. “Whether a surgical team is learning how to work together or a single surgeon is learning a new procedure with a medical device company, all training scenarios can benefit from removing the barriers of time, cost, location, and other resources or variables. Our solution makes it easy to create a training environment whenever someone needs it, not matter where they are.” (MobiHealthNews)
More drug makers join the (temporary) drug price hike freeze bandwagon. Bowing to pressure from the Trump administration, foreign pharmaceutical giants like Roche, Bayer, and Merck KGaA are also pledging to freeze (more) drug prices increases….at least until the end of the year, following in footsteps of Pfizer and Novartis. As we’ve previously explored, it’s hard to know if the moves will have much of a tangible effect on consumers or just how long the detente will last. (Reuters)
THE BIG PICTURE
Salmonella outbreak hits more than half of U.S. states. A salmonella outbreak in 26 U.S. states is linked to raw turkey, according to the Center for Disease Control. So far, 90 people have been infected and 40 hospitalized; for now, public health officials haven’t been able to track the outbreak to a single supplier. (USA Today)
What a Cyber 9/11 Would Mean for the U.S., by Jeff John Roberts
Anxious About a Trade War? Here’s Where to Invest, by Chris Matthews
|Produced by Sy Mukherjee|
Find past coverage. Sign up for other Fortune newsletters.